Confirmation Required for Negative Rapid Group A Streptococcal Test
By LabMedica International staff writers Posted on 11 Jun 2014 |
Image: Scanning electron micrograph of Streptococcus pyogenes, the bacteria associated with Group A streptococcal pharyngitis (Photo courtesy of S. Lowry).
Negative tests results from a rapid analysis of a throat swab for Group A streptococcal (GAS) pharyngitis, performed in a doctor's office should be confirmed through a follow-up laboratory culture.
Clinical guidelines state that negative rapid antigen detection tests (RADTs) for GAS do not require confirmation by a back-up method in adults, whereas laboratory-based guidelines mandate confirmation of a negative RADT in patients of all ages.
Scientists at the University of Washington Medical Center (Seattle, WA, USA) carried out a retrospective analysis of 726 patients, aged 13 and older, with negative RADTs and positive GAS throat cultures performed between January 1, 2000 and Dec 31, 2011, at two academic medical centers in Seattle. Complication rates, treatment, modified Centor score and bacterial burden in patients with negative RADTs and positive GAS throat cultures were assessed.
Modified Centor scores greater than or equal to 2 were observed in 55% of patients with a negative RADT and positive GAS culture. Of these, 77% of patients had a moderate or heavy bacterial burden, equal to or greater than 2+. RADTs failed to detect some patients who presented with serious complications of GAS pharyngitis as 29 (4.0%) had peritonsillar abscesses and two (0.28%) were diagnosed with acute rheumatic fever.
The investigators found culture results to be useful for initiating antibiotic therapy or confirming a clinical diagnosis. Antibiotic treatment was prescribed in 68.7% of patients, with culture-directed initiation of therapy documented in 43.5%. The scientists found that more than 1,000 patients whose rapid throat cultures were negative actually turned out to have Group A Streptococcus in their laboratory throat cultures. Streptococcus pyogenes, was the bacteria associated with Group A streptococcal pharyngitis.
The authors concluded that appropriate use of rapid and culture-based diagnostic tests can reduce inappropriate use of antibiotics for sore throats, while avoiding under-treatment of patients who can benefit from antibiotics. Ferric C. Fang, MD, professor of microbiology and laboratory medicine and senior author of the study said, “Each year nearly seven million Americans seek medical attention for a sore throat, making it one of the most common reasons to see a doctor.” The study was published on May 27, 2014, in the journal Clinical Infectious Diseases.
Related Links:
University of Washington Medical Center
Clinical guidelines state that negative rapid antigen detection tests (RADTs) for GAS do not require confirmation by a back-up method in adults, whereas laboratory-based guidelines mandate confirmation of a negative RADT in patients of all ages.
Scientists at the University of Washington Medical Center (Seattle, WA, USA) carried out a retrospective analysis of 726 patients, aged 13 and older, with negative RADTs and positive GAS throat cultures performed between January 1, 2000 and Dec 31, 2011, at two academic medical centers in Seattle. Complication rates, treatment, modified Centor score and bacterial burden in patients with negative RADTs and positive GAS throat cultures were assessed.
Modified Centor scores greater than or equal to 2 were observed in 55% of patients with a negative RADT and positive GAS culture. Of these, 77% of patients had a moderate or heavy bacterial burden, equal to or greater than 2+. RADTs failed to detect some patients who presented with serious complications of GAS pharyngitis as 29 (4.0%) had peritonsillar abscesses and two (0.28%) were diagnosed with acute rheumatic fever.
The investigators found culture results to be useful for initiating antibiotic therapy or confirming a clinical diagnosis. Antibiotic treatment was prescribed in 68.7% of patients, with culture-directed initiation of therapy documented in 43.5%. The scientists found that more than 1,000 patients whose rapid throat cultures were negative actually turned out to have Group A Streptococcus in their laboratory throat cultures. Streptococcus pyogenes, was the bacteria associated with Group A streptococcal pharyngitis.
The authors concluded that appropriate use of rapid and culture-based diagnostic tests can reduce inappropriate use of antibiotics for sore throats, while avoiding under-treatment of patients who can benefit from antibiotics. Ferric C. Fang, MD, professor of microbiology and laboratory medicine and senior author of the study said, “Each year nearly seven million Americans seek medical attention for a sore throat, making it one of the most common reasons to see a doctor.” The study was published on May 27, 2014, in the journal Clinical Infectious Diseases.
Related Links:
University of Washington Medical Center
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia